Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 15

1.

The psychiatric disease risk factors DISC1 and TNIK interact to regulate synapse composition and function.

Wang Q, Charych EI, Pulito VL, Lee JB, Graziane NM, Crozier RA, Revilla-Sanchez R, Kelly MP, Dunlop AJ, Murdoch H, Taylor N, Xie Y, Pausch M, Hayashi-Takagi A, Ishizuka K, Seshadri S, Bates B, Kariya K, Sawa A, Weinberg RJ, Moss SJ, Houslay MD, Yan Z, Brandon NJ.

Mol Psychiatry. 2011 Oct;16(10):1006-23. doi: 10.1038/mp.2010.87. Epub 2010 Sep 14.

PMID:
20838393
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Phosphodiesterase 11A in brain is enriched in ventral hippocampus and deletion causes psychiatric disease-related phenotypes.

Kelly MP, Logue SF, Brennan J, Day JP, Lakkaraju S, Jiang L, Zhong X, Tam M, Sukoff Rizzo SJ, Platt BJ, Dwyer JM, Neal S, Pulito VL, Agostino MJ, Grauer SM, Navarra RL, Kelley C, Comery TA, Murrills RJ, Houslay MD, Brandon NJ.

Proc Natl Acad Sci U S A. 2010 May 4;107(18):8457-62. doi: 10.1073/pnas.1000730107. Epub 2010 Apr 19.

PMID:
20404172
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

The orphan GPCR, GPR88, modulates function of the striatal dopamine system: a possible therapeutic target for psychiatric disorders?

Logue SF, Grauer SM, Paulsen J, Graf R, Taylor N, Sung MA, Zhang L, Hughes Z, Pulito VL, Liu F, Rosenzweig-Lipson S, Brandon NJ, Marquis KL, Bates B, Pausch M.

Mol Cell Neurosci. 2009 Dec;42(4):438-47. doi: 10.1016/j.mcn.2009.09.007. Epub 2009 Sep 29.

PMID:
19796684
[PubMed - indexed for MEDLINE]
4.

Phosphodiesterase 10A inhibitor activity in preclinical models of the positive, cognitive, and negative symptoms of schizophrenia.

Grauer SM, Pulito VL, Navarra RL, Kelly MP, Kelley C, Graf R, Langen B, Logue S, Brennan J, Jiang L, Charych E, Egerland U, Liu F, Marquis KL, Malamas M, Hage T, Comery TA, Brandon NJ.

J Pharmacol Exp Ther. 2009 Nov;331(2):574-90. doi: 10.1124/jpet.109.155994. Epub 2009 Aug 6.

PMID:
19661377
[PubMed - indexed for MEDLINE]
Free Article
5.

Synthesis, in vitro activities of (2-cyclopropoxyphenyl)piperidine derivatives for alpha 1a and alpha 1d adrenergic receptor inhibitors.

Li S, Chiu G, Pulito VL, Liu J, Connolly PJ, Middleton SA.

Med Chem. 2009 Jan;5(1):15-22.

PMID:
19149646
[PubMed - indexed for MEDLINE]
6.

1-Arylpiperazinyl-4-cyclohexylamine derived isoindole-1,3-diones as potent and selective alpha-1a/1d adrenergic receptor ligands.

Li S, Chiu G, Pulito VL, Liu J, Connolly PJ, Middleton SA.

Bioorg Med Chem Lett. 2007 Mar 15;17(6):1646-50. Epub 2007 Jan 12.

PMID:
17254786
[PubMed - indexed for MEDLINE]
7.

Arylpiperazine substituted heterocycles as selective alpha(1a) adrenergic antagonists.

Khatuya H, Hutchings RH, Kuo GH, Pulito VL, Jolliffe LK, Li X, Murray WV.

Bioorg Med Chem Lett. 2002 Sep 2;12(17):2443-6.

PMID:
12161153
[PubMed - indexed for MEDLINE]
8.

Novel thiophene derivatives for the treatment of benign prostatic hyperplasia.

Khatuya H, Pulito VL, Jolliffe LK, Li X, Murray WV.

Bioorg Med Chem Lett. 2002 Aug 19;12(16):2145-8.

PMID:
12127524
[PubMed - indexed for MEDLINE]
9.

An investigation of the uroselective properties of four novel alpha(1a)-adrenergic receptor subtype-selective antagonists.

Pulito VL, Li X, Varga SS, Mulcahy LS, Clark KS, Halbert SA, Reitz AB, Murray WV, Jolliffe LK.

J Pharmacol Exp Ther. 2000 Jul;294(1):224-9.

PMID:
10871316
[PubMed - indexed for MEDLINE]
Free Article
10.

In vitro characterization of five humanized OKT3 effector function variant antibodies.

Xu D, Alegre ML, Varga SS, Rothermel AL, Collins AM, Pulito VL, Hanna LS, Dolan KP, Parren PW, Bluestone JA, Jolliffe LK, Zivin RA.

Cell Immunol. 2000 Feb 25;200(1):16-26.

PMID:
10716879
[PubMed - indexed for MEDLINE]
11.

Humanization and molecular modeling of the anti-CD4 monoclonal antibody, OKT4A.

Pulito VL, Roberts VA, Adair JR, Rothermel AL, Collins AM, Varga SS, Martocello C, Bodmer M, Jolliffe LK, Zivin RA.

J Immunol. 1996 Apr 15;156(8):2840-50.

PMID:
8609403
[PubMed - indexed for MEDLINE]
12.

Humanization of the murine anti-human CD3 monoclonal antibody OKT3.

Adair JR, Athwal DS, Bodmer MW, Bright SM, Collins AM, Pulito VL, Rao PE, Reedman R, Rothermel AL, Xu D, et al.

Hum Antibodies Hybridomas. 1994;5(1-2):41-7.

PMID:
7858182
[PubMed - indexed for MEDLINE]
13.

Effect of a single amino acid mutation on the activating and immunosuppressive properties of a "humanized" OKT3 monoclonal antibody.

Alegre ML, Collins AM, Pulito VL, Brosius RA, Olson WC, Zivin RA, Knowles R, Thistlethwaite JR, Jolliffe LK, Bluestone JA.

J Immunol. 1992 Jun 1;148(11):3461-8.

PMID:
1534096
[PubMed - indexed for MEDLINE]
14.

ADP-ribosyltransferase activity during the friend virus-induced murine erythroleukemia cell differentiation.

Pulito VL, Miller DL, Sassa S, Yamane T.

J Biol Chem. 1983 Dec 25;258(24):14756-8.

PMID:
6317670
[PubMed - indexed for MEDLINE]
Free Article
15.

DNA fragments in Friend erythroleukemia cells induced by dimethyl sulfoxide.

Pulito VL, Miller DL, Sassa S, Yamane T.

Proc Natl Acad Sci U S A. 1983 Oct;80(19):5912-5.

PMID:
6310603
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk